These souped-up versions may help overcome some limitations of existing CAR T cells. — ScienceDaily
Immunotherapies called chimeric antigen receptor (CAR) T cells use genetically engineered versions of a patient’s own immune cells to fight cancer. These treatments have energized cancer care, especially for people…
